SCHEMBL3484893

SCHEMBL3484893

CC(C)N1C(=O)CCOc2cc(F)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ2 O43526 1/20 0.38
AKR1B1 P15121 1/20 0.38
NR3C1 P04150 2/20 0.37
NR3C2 P08235 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PIK3CD O00329 3/20 0.36
PIK3R1 P27986 2/20 0.36
MTOR P42345 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36
FABP6 P51161 1/20 0.35
PGR P06401 1/20 0.35
ALDH1A1 P00352 2/20 0.35
RIPK1 Q13546 1/20 0.35
HTT P42858 1/20 0.35
RECQL P46063 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30921780 0.85 PIK3CD (0.46) KCNQ2NR3C1NR3C2PIK3CDPIK3R1
SCHEMBL3485497 0.74 NR3C2 (0.38) NR3C1NR3C2PGRCHRM5CHRM1
SCHEMBL3486153 0.74 NR3C2 (0.38) NR3C1NR3C2PGRCHRM5CHRM1
SCHEMBL1270708 0.74 NOTUM (0.43) KCNQ2SMN1; SMN2CYP2D6CYP2C9ALDH1A1
SCHEMBL24359222 0.73 SRD5A1 (0.41) SMN1; SMN2CYP2D6CYP2C9CHRM1CHRM3
SCHEMBL17169807 0.73 RIPK1 (0.40) KCNQ2NR3C1NR3C2PIK3CDPIK3CB
SCHEMBL24224444 0.72 ALDH1A1 (0.46) SMN1; SMN2CYP2D6CYP2C9ALDH1A1KRAS
SCHEMBL15964655 0.72 TRPV1 (0.44) AKR1B1FABP6ALDH1A1NPY5RKRAS
SCHEMBL13962148 0.71 CYP11B2 (0.36) SMN1; SMN2PIK3CDPIK3R1MTORCYP2D6
SCHEMBL16601585 0.69 HTT (0.45) PIK3CDPIK3R1MTORCYP2D6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100144715-A1 Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers MERCK SHARP & DOHME CORP. 2010-06-10 US disclosed
US-20100144715-A1 Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers MERCK SHARP & DOHME CORP. 2010-06-10 US disclosed
US-20100144715-A1 Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers MERCK SHARP & DOHME CORP. 2010-06-10 US disclosed
EP-2131657-A1 SUBSTITUTED BENZODIAZEPINONES, BENZOXAZEPINONES AND BENZOTHIAZEPINONES AS SODIUM CHANNEL BLOCKERS Merck & Co., Inc. (US) 2009-12-16 EP disclosed
WO-2008106077-A1 SUBSTITUTED BENZODIAZEPINONES, BENZOXAZEPINONES AND BENZOTHIAZEPINONES AS SODIUM CHANNEL BLOCKERS MERCK & CO., INC. (US) 2008-09-04 WO disclosed
WO-2008106077-A1 SUBSTITUTED BENZODIAZEPINONES, BENZOXAZEPINONES AND BENZOTHIAZEPINONES AS SODIUM CHANNEL BLOCKERS MERCK & CO., INC. (US) 2008-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144715-A1 Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers TRPV1, TRPV4, CACNA1B KCNQ2 10/4885AKR1B1 892/4885NR3C1 581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.